Molecular Insight Pharmaceuticals
As of January 22, 2013, Molecular Insight Pharmaceuticals has been acquired by Progenics Pharmaceuticals. Molecular Insight Pharmaceuticals, Inc. develops therapeutic radiopharmaceuticals and molecular imaging agents for use in oncology and cardiology. The company targets the development of a small-molecule chemistry platform to improve detection of primary and metastatic prostate cancer and to provide a systemic radiotherapy for relapsed and metastatic prostate cancer. Its products include technetium Tc 99m trofolastat, a clinical-stage molecular imaging agent for patients with metastatic prostate cancer; and 131I-MIP-1095, a prostate cancer therapy for systemic delivery of radiotherapy.
Molecular Insight Pharmaceuticals
As of January 22, 2013, Molecular Insight Pharmaceuticals has been acquired by Progenics Pharmaceuticals. Molecular Insight Pharmaceuticals, Inc. develops therapeutic radiopharmaceuticals and molecular imaging agents for use in oncology and cardiology. The company targets the development of a small-molecule chemistry platform to improve detection of primary and metastatic prostate cancer and to provide a systemic radiotherapy for relapsed and metastatic prostate cancer. Its products include technetium Tc 99m trofolastat, a clinical-stage molecular imaging agent for patients with metastatic prostate cancer; and 131I-MIP-1095, a prostate cancer therapy for systemic delivery of radiotherapy.
molecularinsight.com
160 2nd St Cambridge, Massachusetts 02142, US
Details
Year founded
1997
Revenue
10M-25M
Employees
51-200
Number of locations
1
NAICS
3254
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Molecular medicine
- Novel biopharmaceutical
- Radio therapeutics
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- MMI CellCut laser microdissection machine
- MMI CellScan whole slide scanner
- MMI CellEctor cell picker
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that molecular insight pharmaceuticals is not ramping up production.
Target industries
Employees working in Molecular Insight Pharmaceuticals
Locations (1)
Molecular Insight Pharmaceuticals
160 2nd St Cambridge, Massachusetts 02142, US
People Also Searched For
Frequently Asked Questions
What services & capabilities does Molecular Insight Pharmaceuticals offer?
Molecular Insight Pharmaceuticals offers a range of services and capabilities, including Molecular medicine.
What kind of equipment does Molecular Insight Pharmaceuticals use?
Molecular Insight Pharmaceuticals uses a variety of equipment, including MMI CellCut laser microdissection machine.
What are the target industries of Molecular Insight Pharmaceuticals?
Molecular Insight Pharmaceuticals serves several industries, including the defense industry.
How many locations does Molecular Insight Pharmaceuticals operate?
Molecular Insight Pharmaceuticals operates from a single location at 160 2nd street, cambridge, massachusetts 02142, united states.
Where are the headquarters of Molecular Insight Pharmaceuticals?
The headquarters of Molecular Insight Pharmaceuticals are located in 160 2nd street, cambridge, massachusetts 02142, united states.
What is the NAICS code for Molecular Insight Pharmaceuticals?
The NAICS code for Molecular Insight Pharmaceuticals is 3254.
How many employees does Molecular Insight Pharmaceuticals have?
Molecular Insight Pharmaceuticals has 61 employees.
What is the official website of Molecular Insight Pharmaceuticals?
The official website of Molecular Insight Pharmaceuticals is https://molecularinsight.com/.
When was Molecular Insight Pharmaceuticals founded?
Molecular Insight Pharmaceuticals was founded in 1997.